Home » Newsletters » BioWorld Science

BioWorld Science

June 8, 2010

View Archived Issues

Denufosol improves lung function in patients with cystic fibrosis

Lixivaptan evaluated vs. furosemide in healthy volunteers

Tirofiban shows safety/preliminary efficacy in BAO and stroke

Merck & Co. claims new neuropeptide S receptor antagonists

New immunoprophylactic antibacterial CLDC+MPF combination presented

Aclidinium bromide shows preliminary efficacy in COPD

NeuroSearch discloses new GABA(A) receptor modulators

Lilly claims new hedgehog signaling inhibitors

New FABP inhibitors presented

MDX-1097 is evaluated in phase I trial in multiple myeloma

Phase I trial data presented on GSK-923295 in solid tumors

GlaxoSmithKline discloses highlights of first quarter 2010

PolyMedix completes phase Ib trial of PMX-60056 for reversal of heparin action

Ascenta and sanofi-aventis sign license agreement in oncology

Scancell and ImmuneRegen BioSciences form strategic alliance

H4 receptor antagonist UR-63325 yields favorable first-in-human data

AstraZeneca submits Axanum MAA in E.U.

Bausch and Lomb acquires Zirgan ophthalmic gel from Sirion

TauRx and Bayer Schering enter into AD collaboration

Preliminary phase III data reported on oral insulin spray

Janssen expands licensing agreement for tapentadol

FDA grants orphan drug status to GVAX CML vaccine

CombinatoRx receives milestone payment for Prednisporin

Grifols to acquire Talecris Biotherapeutics

TK therapy R&D project receives grant from Regione Lombardia

FDA accepts DM-1796 NDA for postherpetic neuralgia

Phase III trial of plitidepsin initiated in multiple myeloma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Rare earth: Biomarin to use global reach post-$4.8B Amicus buy
BioWorld
Biomarin Pharmaceutical Inc. followed up its May takeover of Inozyme Pharma Inc. with a much larger agreement to acquire Amicus Therapeutics Inc. for $14.50 per...